Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter safety monitoring study of inhaled zanamivir in Chinese adolescents and adults with influenza
ChiCTR-TNRC-10000938Phase 4Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zanamivir in influenza, sponsored by Beijing Chaoyang Hospital. Primary endpoint: Serious adverse events and unexpected serious adverse events. Started Sep 2009; status: completed.
02
Drugs
zanamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR-TNRC-10000938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-10000938.